FOLH1 and prostate cancer: One of the aptamers, A10, when the central region was truncated from 40 nt to 25 nt, could still bind to the PSMA-positive LNCaP prostate cancer cells specifically but not to the PSMA-negative PC-3 prostate cancer cells [91].